BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23917280)

  • 1. Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.
    Green RC; Lupski JR; Biesecker LG
    JAMA; 2013 Jul; 310(4):365-6. PubMed ID: 23917280
    [No Abstract]   [Full Text] [Related]  

  • 2. Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making.
    Ross LF; Rothstein MA; Clayton EW
    JAMA; 2013 Jul; 310(4):367-8. PubMed ID: 23917281
    [No Abstract]   [Full Text] [Related]  

  • 3. Return of secondary genomic findings vs patient autonomy: implications for medical care.
    Klitzman R; Appelbaum PS; Chung W
    JAMA; 2013 Jul; 310(4):369-70. PubMed ID: 23917282
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomic test validation for incidental findings.
    Park JY; Fortina P; Kricka LJ
    Clin Chem; 2014 Feb; 60(2):292-3. PubMed ID: 23818443
    [No Abstract]   [Full Text] [Related]  

  • 5. Point-counterpoint. Ethics and genomic incidental findings.
    McGuire AL; Joffe S; Koenig BA; Biesecker BB; McCullough LB; Blumenthal-Barby JS; Caulfield T; Terry SF; Green RC
    Science; 2013 May; 340(6136):1047-8. PubMed ID: 23686340
    [No Abstract]   [Full Text] [Related]  

  • 6. Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.
    Regier DA; Peacock SJ; Pataky R; van der Hoek K; Jarvik GP; Hoch J; Veenstra D
    CMAJ; 2015 Apr; 187(6):E190-E197. PubMed ID: 25754703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the incidentalome when targeting the tumor genome.
    Bombard Y; Robson M; Offit K
    JAMA; 2013 Aug; 310(8):795-6. PubMed ID: 23982363
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.
    Christenhusz GM; Devriendt K; Van Esch H; Dierickx K
    Med Health Care Philos; 2015 Aug; 18(3):361-70. PubMed ID: 25407129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.
    Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
    BMC Med Ethics; 2020 Jan; 21(1):9. PubMed ID: 32000764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.
    Christenhusz GM; Devriendt K; Dierickx K
    Eur J Hum Genet; 2013 Mar; 21(3):248-55. PubMed ID: 22739341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines.
    Anderson JA; Hayeems RZ; Shuman C; Szego MJ; Monfared N; Bowdin S; Zlotnik Shaul R; Meyn MS
    Clin Genet; 2015 Apr; 87(4):301-10. PubMed ID: 25046648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.
    Boardman F; Hale R
    Mol Genet Genomic Med; 2018 Nov; 6(6):1079-1096. PubMed ID: 30370638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal utility in genomic testing: is there such a thing?
    Bunnik EM; Janssens AC; Schermer MH
    J Med Ethics; 2015 Apr; 41(4):322-6. PubMed ID: 24872596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining categories of actionability for secondary findings in next-generation sequencing.
    Moret C; Mauron A; Fokstuen S; Makrythanasis P; Hurst SA
    J Med Ethics; 2017 May; 43(5):346-349. PubMed ID: 28039284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Return of results: not that complicated?
    Evans JP; Rothschild BB
    Genet Med; 2012 Apr; 14(4):358-60. PubMed ID: 22481183
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.
    Daack-Hirsch S; Driessnack M; Hanish A; Johnson VA; Shah LL; Simon CM; Williams JK
    Clin Genet; 2013 Jul; 84(1):11-8. PubMed ID: 23590238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grappling with genomic incidental findings in the clinical realm.
    Hull SC; Berkman BE
    Chest; 2014 Feb; 145(2):226-230. PubMed ID: 24493507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding common ground.
    Evans JP
    Genet Med; 2013 Nov; 15(11):852-3. PubMed ID: 24136615
    [No Abstract]   [Full Text] [Related]  

  • 20. Reporting practices for variants of uncertain significance from next generation sequencing technologies.
    Vears DF; Sénécal K; Borry P
    Eur J Med Genet; 2017 Oct; 60(10):553-558. PubMed ID: 28774848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.